Plasma levels of soluble Axl correlate with severity of community-acquired pneumonia

Molecular Medicine Reports

Volumn 9, Issue 4, 2014, Pages 1400-1404

  Ko, Chung Po ^a,b   Yu, Yung Luen ^c,d   Hsiao, Pei Ching ^a,e   Yang, Shun Fa ^a,e   Yeh, Chao Bin ^a,e  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute physiology and chronic health evaluation II score; Community acquired pneumonia; CURB 65; Pneumonia severity index score; Soluble axl

Indexed keywords

C REACTIVE PROTEIN; PROTEIN TYROSINE KINASE; SOLUBLE AXL PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC THERAPY; APACHE; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUTROPHIL COUNT; PNEUMONIA SEVERITY INDEX; PROTEIN BLOOD LEVEL;

ADULT; APACHE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; DEMOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; PNEUMONIA; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SEVERITY OF ILLNESS INDEX; SOLUBILITY;

EID: 84896526352     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.1933     Document Type: Article

References (22)

1. Kumar V, Abbas AK, Fausto N, et al: Pathologic Basis of Disease, 8th ed. Elsevier Saunders, Philadelphia, PA, pp710-711, 2009.
2. Chiang TY, Shyu LY, Tsao TC, et al: Elevated plasma matrix metalloproteinase-9 protein and its gene polymorphism in patients with community-acquired pneumonia. Clin Chem Lab Med 50: 449-454, 2011.
3. Lee YT, Chen SC, Shyu LY, et al: Significant elevation of plasma cathepsin B and cystatin C in patients with community-acquired pneumonia. Clin Chim Acta 413: 630-635, 2012.
4. Houck PM, Bratzler DW, Nsa W, Ma A and Bartlett JG: Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 164: 637-644, 2004. (Pubitemid 38392978)
5. Ekman C, Gottsäter A, Lindblad B and Dahlbäck B: Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia. Clin Biochem 43: 873-876, 2010.
6. Ekman C, Linder A, Akesson P and Dahlbäck B: Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes. Crit Care 14: R158, 2010.
7. Hafizi S and Dahlbäck B: Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J 273: 5231-5244, 2006. (Pubitemid 44772384)
8. Gheita TA, Bassyouni IH and Bassyouni RH: Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with Systemic lupus erythematosus and Behçets disease. J Clin Immunol 32: 1279-1286, 2012.
9. Mandell LA, Wunderink RG, Anzueto A, et al: Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management ofcommunity-acquired pneumonia in adults. Clin Infect Dis 44: S27-S72, 2007. (Pubitemid 46290553)
10. Fine MJ, Auble TE, Yealy DM, et al: A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336: 243-250, 1997. (Pubitemid 27044625)
11. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: a severity of disease classification system. Crit Care Med 13: 818-829, 1985. (Pubitemid 15250137)
12. Lim WS, van der Eerden MM, Laing R, et al: Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58: 377-382, 2003. (Pubitemid 36560938)
13. Melaragno MG, Wuthrich DA, Poppa V, et al: Increased expression of Axl tyrosine kinase after vascular injury and regulation by G protein-coupled receptor agonists in rats. Circ Res 83: 697-704, 1998. (Pubitemid 28462783)
14. Ekman C, Site DF, Gottsäter A, Lindblad B and Dahlbäck B: Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl as markers of large abdominal aortic aneurysms. Clin Biochem 43: 110-114, 2010.
15. Robinson DR, Wu YM and Lin SF: The protein tyrosine kinase family of the human genome. Oncogene 19: 5548-5557, 2000.
16. Linger RM, Keating AK, Earp HS and Graham DK: TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res 100: 35-83, 2008. (Pubitemid 351932179)
17. Manfioletti G, Brancolini C, Avanzi G and Schneider C: The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol 13: 4976-4985, 1993. (Pubitemid 23220402)
18. O'Bryan JP, Frye RA, Cogswell PC, et al: Axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 11: 5016-5031, 1991. (Pubitemid 21895263)
19. Vajkoczy P, Knyazev P, Kunkel A, et al: Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. Proc Natl Acad Sci USA 103: 5799-5804, 2006.
20. Sawabu T, Seno H, Kawashima T, et al: Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway. Mol Carcinog 46: 155-164, 2007.
21. Lee IJ, Hilliard B, Swami A, et al: Growth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure. Nephrol Dial Transplant 27: 4166-4172, 2012.
22. Ekman C, Jönsen A, Sturfelt G, Bengtsson AA and Dahlbäck B: Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus. Rheumatology (Oxford) 50: 1064-1069, 2011.